Ignite Creation Date:
2024-05-06 @ 1:58 AM
Last Modification Date:
2024-10-26 @ 11:11 AM
Study NCT ID:
NCT01933919
Status:
COMPLETED
Last Update Posted:
2017-12-04
First Post:
2013-08-29
Brief Title:
A Phase 3 Study of Fluvoxamine SME3110 in PediatricAdolescent Patients With Obsessive Compulsive Disorder
Sponsor:
AbbVie
Organization:
AbbVie
Organization Data
Organization:
AbbVie
Class:
INDUSTRY
Study ID:
M13-970
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
AbbVie
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| Meiji Seika Pharma Co Ltd | INDUSTRY |